Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint
CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study...
Beyfortus® (nirsevimab) now available in Malaysia to protect all infants against RSV disease
Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying conditions – against respiratory syncytial virus (RSV), with proven high and sustained efficacy, a...
AI-Powered Subscription Solutions by Subotiz Featured at Singapore FinTech Festival 2025
SINGAPORE, Nov. 21, 2025 /PRNewswire/ -- Subotiz, an emerging fintech platform powering AI-driven subscription and payment solutions, was recently featured at the Singapore FinTech Festival (SFF 2025), a global stage for innovation in finance and...
SUS ENVIRONMENT at COP30: Co-building a Brighter Tomorrow with Waste-to-Energy
SHANGHAI, Nov. 20, 2025 /PRNewswire/ -- From November 10 to 21, 2025, the 30th United Nations Climate Change Conference (COP 30) was held in Belem, Brazil. Over 50,000 delegates from more than 190 countries and regions attended, jointly advancing...
Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis
HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, today announced key results from its...
MindHYVE's ChironAI™ Showcased at Peshawar Institute of Cardiology's CME on Cardiovascular Imaging Innovation"
PESHAWAR, Pakistan, Nov. 18, 2025 /PRNewswire/ -- The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) hosted a high-profile Radiology Continuing Medical Education (CME) session on "Innovations in Cardiovascular Imaging,"...
Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research
DURHAM, N.C. and SEOUL, South Korea, Nov. 17, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, today announced a...
WKBC 2025: CLEARCHANG Highlights Korean Engineering Excellence in Air Purifier and Indoor Air Purification Systems
In Atlanta, CLEARCHANG's window-mounted air purifier demonstrated the synergy of design, ventilation, and sustainable indoor air purification. SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- CLEARCHANG Co., Ltd., a pioneer in advanced air purifier...
Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions
NEW ORLEANS, Nov. 10, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 achieved...
Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress
CHENGDU, China, Nov. 10, 2025 /PRNewswire/ -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association (CACA),...